Montpensier Arbervel
Investor profile | Builders Republic
About
Montpensier Arbevel is a major independent French asset management firm resulting from the strategic merger of Montpensier Finance and Financière Arbevel in January 2025. Combining entrepreneurial DNA with institutional scale, the firm manages over €5 billion across public and private markets. While widely recognized for its active management in listed equities (SME/ETI) and convertible bonds, Montpensier Arbevel operates a distinct "Private Markets" division inherited primarily from Arbevel's expertise. This division focuses on Private Equity and Private Debt, supporting innovative growth companies—particularly in the healthcare and deeptech sectors—through cross-over strategies and direct unlisted investments.
Key facts
- Type
- IM / Cross-over Fund
- Stages
- Series B,Growth
- Sectors
- Healthcare,Biotech
- Headquarters
- France
- Offices
- Paris
- Geographic focus
- France
- Lead / Follow
- Can lead and follow
- Ticket size
- 1M€ – 8M€
- Founded
- 2004
Track record
- Total investments: 13
Notable investments in France
Uromems, Germitec, Keranova, NG Biotech, CorWave
Key differentiators
Multi-Assets Fund,Sector Specialist,Growth Lending